Xenon Pharmaceuticals to Present at the Wells Fargo 2022 Healthcare ConferenceGlobeNewsWire • 09/01/22
Xenon Pharmaceuticals Inc. (XENE) CEO Ian Mortimer on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/10/22
Xenon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate UpdateGlobeNewsWire • 08/09/22
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Second Quarter 2022 Financial Results and Provide Corporate UpdateGlobeNewsWire • 08/02/22
Xenon Pharmaceuticals to Present at the William Blair Biotech Focus Conference 2022GlobeNewsWire • 07/11/22
Xenon Pharmaceuticals Announces Closing of $287.5 Million Public Offering Including Full Exercise of the Underwriters' Option to Purchase Additional SharesGlobeNewsWire • 06/27/22
Xenon Pharmaceuticals Provides Update on Additional Positive Data from the XEN1101 ProgramGlobeNewsWire • 06/22/22
Xenon Pharmaceuticals Announces Positive Outcome of End-of-Phase 2 Meeting with the FDAGlobeNewsWire • 06/21/22
Xenon Pharmaceuticals (XENE) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/10/22
Xenon Pharmaceuticals Inc. (XENE) CEO Ian Mortimer on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/10/22
Xenon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate UpdateGlobeNewsWire • 05/10/22
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2022 Financial Results and Provide Corporate UpdateGlobeNewsWire • 05/03/22
Xenon Pharmaceuticals to Present at the 21st Annual Needham Virtual Healthcare ConferenceGlobeNewsWire • 04/04/22
Xenon Pharmaceuticals Inc. (XENE) CEO Ian Mortimer on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/02/22
Xenon Pharmaceuticals Reports 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire • 03/01/22
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Year-End 2021 Financial Results and Provide Corporate UpdateGlobeNewsWire • 02/22/22
Xenon Pharmaceuticals to Participate in the 11th Annual SVB Leerink Global Healthcare ConferenceGlobeNewsWire • 02/14/22
Xenon Pharmaceuticals Announces Collaboration with Neurocrine Biosciences Achieves $15.0 Million Regulatory MilestoneGlobeNewsWire • 01/12/22